Related Experiment Video
Updated: Oct 9, 2025

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
Limited Evidence for Use of a Black Race Modifier in eGFR Calculations: A Systematic Review
Mark A Marzinke1, Dina N Greene2, Patrick M Bossuyt3
1Departments of Pathology and Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Limited evidence supports using a Black race modifier (BRM) in estimated glomerular filtration rate (eGFR) equations. Removing the BRM may improve early detection of chronic kidney disease (CKD) but requires careful clinical consideration.
Area of Science:
- Nephrology
- Clinical Chemistry
- Health Equity
Background:
- Estimated glomerular filtration rate (eGFR) equations often incorporate a Black race modifier (BRM).
- Race is a social construct with inconsistent clinical application, affecting eGFR calculations.
- The BRM elevates eGFR in Black individuals, potentially masking kidney disease.
Purpose of the Study:
- To systematically evaluate literature on eGFR equations with and without the BRM.
- To examine the clinical impact of including or excluding the BRM in eGFR calculations.
- To assess the evidence supporting the use of the BRM in clinical practice.
Main Methods:
- Searched PubMed and Embase for studies comparing measured GFR to eGFR in diverse adult populations.
- Included studies using Modification of Diet in Renal Disease or CKD Epidemiology Collaboration equations.
- Analyzed 96 studies, with 44 selected for final assessment of eGFR equations with and without BRM.
Main Results:
- Limited published evidence supports the use of a BRM in eGFR equations.
- Equations without the BRM may enable earlier detection of chronic kidney disease (CKD).
- Potential for over-diagnosis of CKD or impact on downstream interventions exists when removing the BRM.
Conclusions:
- The evidence base for employing a BRM in eGFR equations is currently weak.
- Further research is needed to understand the full clinical implications of removing the BRM.
- Clinical decisions regarding eGFR calculation should consider the limitations of race-based modifiers.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Mitogens and the Cell Cycle

